FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1770371122> ?p ?o ?g. }

• W1770371122 endingPage "6" @default.
• W1770371122 startingPage "712" @default.
• W1770371122 abstract "There is a continuing interest in increasing the statistical efficiency of the analysis of clinically meaningful endpoints in rheumatology. One issue that is attracting increasing attention is whether the conventional practice of only reporting the outcome at the end of the study (EOS) might be replaced or complemented by a longitudinal summary that better reflects the clinical course of the disease. The area under the curve (AUC) is a summary measure that integrates serial assessments of a patient's endpoint over the duration of the study. We evaluated the utility of AUC as a summary measure for the analysis and reporting of two RA trials: (i) methotrexate combined with cyclosporine versus methotrexate and placebo in partial methotrexate responders in relatively late disease, and (ii) prednisone plus methotrexate plus sulfasalazine versus sulfasalazine alone in relatively early disease. We replicated the published results of each trial first using the conventional EOS and then AUC summaries. For each patient, the changes from baseline over time were transformed into a summary measure by calculating AUC using the trapezium rule and then standardizing it by the study duration. Using an approach similar to the index of responsiveness to change, we scaled treatment differences derived from EOS and AUC summary measures by their standard deviation of the control group. This signal-versus-noise ratio captures the treatment discrimination ability of each summary measure. Compared to EOS and within each treatment group, the AUC summary reported smaller effects (i.e., change from baseline) with reduced errors in the estimates. AUC measures preserved discriminant validity in treatment comparisons and reported smaller but more precise treatment effect estimates. In the COBRA trial with rapidly-acting medications, AUC seemed to be more sensitive than EOS to detect treatment difference. With slow acting medications and in relatively late disease patients as in the cyclosporine trial, EOS was more sensitive to detect treatment difference than was AUC. In this setting, AUC, however, still seemed to be more sensitive than EOS for the two responsive-to-change endpoints: tender joint counts and pain by visual analog scale. AUC integrates repeated assessments during the trial duration into summary measures. Compared to EOS, the report of RA trial results using AUC summary provides smaller estimates of treatment effects but with better precision. AUC summary is likely to preserve treatment group discrimination taking into account the appropriate onset and offset of the drug action. Trial reports using AUC summary have smaller effect sizes. For trials with long acting medications and short duration similar to the cyclosporine trial, AUC still preserves treatment discrimination but may not be as sensitive as EOS. The calculations of AUC require some additional work in the analysis of each endpoint." @default.
• W1770371122 created "2016-06-24" @default.
• W1770371122 creator A5035644440 @default.
• W1770371122 creator A5044831604 @default.
• W1770371122 creator A5056208570 @default.
• W1770371122 creator A5066860826 @default.
• W1770371122 creator A5068779654 @default.
• W1770371122 creator A5088811355 @default.
• W1770371122 date "1999-03-01" @default.
• W1770371122 modified "2023-10-18" @default.
• W1770371122 title "Validity of area-under-the-curve analysis to summarize effect in rheumatoid arthritis clinical trials." @default.
• W1770371122 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10090188" @default.
• W1770371122 hasPublicationYear "1999" @default.
• W1770371122 type Work @default.
• W1770371122 sameAs 1770371122 @default.
• W1770371122 citedByCount "20" @default.
• W1770371122 countsByYear W17703711222015 @default.
• W1770371122 countsByYear W17703711222017 @default.
• W1770371122 countsByYear W17703711222018 @default.
• W1770371122 countsByYear W17703711222019 @default.
• W1770371122 countsByYear W17703711222022 @default.
• W1770371122 crossrefType "journal-article" @default.
• W1770371122 hasAuthorship W1770371122A5035644440 @default.
• W1770371122 hasAuthorship W1770371122A5044831604 @default.
• W1770371122 hasAuthorship W1770371122A5056208570 @default.
• W1770371122 hasAuthorship W1770371122A5066860826 @default.
• W1770371122 hasAuthorship W1770371122A5068779654 @default.
• W1770371122 hasAuthorship W1770371122A5088811355 @default.
• W1770371122 hasConcept C126322002 @default.
• W1770371122 hasConcept C142724271 @default.
• W1770371122 hasConcept C1862650 @default.
• W1770371122 hasConcept C198451711 @default.
• W1770371122 hasConcept C204787440 @default.
• W1770371122 hasConcept C27081682 @default.
• W1770371122 hasConcept C2777575956 @default.
• W1770371122 hasConcept C2778720950 @default.
• W1770371122 hasConcept C2779134260 @default.
• W1770371122 hasConcept C2779383735 @default.
• W1770371122 hasConcept C2780479503 @default.
• W1770371122 hasConcept C2781059491 @default.
• W1770371122 hasConcept C535046627 @default.
• W1770371122 hasConcept C71924100 @default.
• W1770371122 hasConcept C76318530 @default.
• W1770371122 hasConceptScore W1770371122C126322002 @default.
• W1770371122 hasConceptScore W1770371122C142724271 @default.
• W1770371122 hasConceptScore W1770371122C1862650 @default.
• W1770371122 hasConceptScore W1770371122C198451711 @default.
• W1770371122 hasConceptScore W1770371122C204787440 @default.
• W1770371122 hasConceptScore W1770371122C27081682 @default.
• W1770371122 hasConceptScore W1770371122C2777575956 @default.
• W1770371122 hasConceptScore W1770371122C2778720950 @default.
• W1770371122 hasConceptScore W1770371122C2779134260 @default.
• W1770371122 hasConceptScore W1770371122C2779383735 @default.
• W1770371122 hasConceptScore W1770371122C2780479503 @default.
• W1770371122 hasConceptScore W1770371122C2781059491 @default.
• W1770371122 hasConceptScore W1770371122C535046627 @default.
• W1770371122 hasConceptScore W1770371122C71924100 @default.
• W1770371122 hasConceptScore W1770371122C76318530 @default.
• W1770371122 hasIssue "3" @default.
• W1770371122 hasLocation W17703711221 @default.
• W1770371122 hasOpenAccess W1770371122 @default.
• W1770371122 hasPrimaryLocation W17703711221 @default.
• W1770371122 hasRelatedWork W1649198301 @default.
• W1770371122 hasRelatedWork W1770371122 @default.
• W1770371122 hasRelatedWork W1873084555 @default.
• W1770371122 hasRelatedWork W2051823061 @default.
• W1770371122 hasRelatedWork W2093022889 @default.
• W1770371122 hasRelatedWork W2352009657 @default.
• W1770371122 hasRelatedWork W2736393579 @default.
• W1770371122 hasRelatedWork W2756141479 @default.
• W1770371122 hasRelatedWork W2804881982 @default.
• W1770371122 hasRelatedWork W3093461595 @default.
• W1770371122 hasVolume "26" @default.
• W1770371122 isParatext "false" @default.
• W1770371122 isRetracted "false" @default.
• W1770371122 magId "1770371122" @default.
• W1770371122 workType "article" @default.